Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 16 studies | 28% ± 11% | |
fibroblast | 15 studies | 33% ± 12% | |
pericyte | 15 studies | 29% ± 10% | |
endothelial cell | 11 studies | 27% ± 12% | |
connective tissue cell | 9 studies | 33% ± 14% | |
myofibroblast cell | 8 studies | 36% ± 17% | |
kidney distal convoluted tubule epithelial cell | 4 studies | 26% ± 9% | |
mesothelial cell | 4 studies | 38% ± 11% | |
epithelial cell | 4 studies | 30% ± 13% | |
basal cell | 4 studies | 24% ± 8% | |
ciliated cell | 4 studies | 24% ± 11% | |
capillary endothelial cell | 3 studies | 27% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2798.29 | 245 / 245 | 99% | 40.41 | 498 / 502 |
ovary | 100% | 6682.88 | 180 / 180 | 99% | 170.73 | 426 / 430 |
uterus | 100% | 5676.17 | 170 / 170 | 97% | 39.80 | 443 / 459 |
lung | 99% | 2239.17 | 574 / 578 | 95% | 26.02 | 1094 / 1155 |
esophagus | 100% | 4552.52 | 1445 / 1445 | 94% | 37.81 | 172 / 183 |
pancreas | 100% | 2076.83 | 327 / 328 | 93% | 21.09 | 166 / 178 |
thymus | 99% | 1272.17 | 648 / 653 | 91% | 17.66 | 548 / 605 |
stomach | 99% | 1866.88 | 357 / 359 | 90% | 31.99 | 258 / 286 |
bladder | 100% | 2044.05 | 21 / 21 | 89% | 22.80 | 449 / 504 |
kidney | 100% | 3359.60 | 89 / 89 | 89% | 19.33 | 801 / 901 |
intestine | 98% | 1944.67 | 951 / 966 | 88% | 26.19 | 465 / 527 |
skin | 93% | 1150.92 | 1674 / 1809 | 91% | 19.57 | 428 / 472 |
adrenal gland | 100% | 5383.80 | 258 / 258 | 68% | 28.10 | 157 / 230 |
brain | 71% | 693.83 | 1870 / 2642 | 82% | 11.71 | 579 / 705 |
breast | 98% | 1452.17 | 449 / 459 | 54% | 11.68 | 604 / 1118 |
liver | 76% | 487.91 | 172 / 226 | 60% | 13.45 | 244 / 406 |
adipose | 100% | 1987.39 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2019.65 | 1328 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 33.26 | 79 / 80 |
spleen | 97% | 1230.10 | 234 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 22.84 | 41 / 45 |
heart | 86% | 723.60 | 744 / 861 | 0% | 0 | 0 / 0 |
muscle | 22% | 135.56 | 179 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.98 | 5 / 29 |
peripheral blood | 3% | 23.11 | 25 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0061351 | Biological process | neural precursor cell proliferation |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0070315 | Biological process | G1 to G0 transition involved in cell differentiation |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF503 |
Protein name | Zinc finger protein 503 |
Synonyms | NOLZ1 |
Description | FUNCTION: May function as a transcriptional repressor. . |
Accessions | Q96F45 ENST00000372524.5 [Q96F45-1] |